...
首页> 外文期刊>Archives of clinical infectious diseases. >Seroprevalence of Toxoplasma gondii Infection in Patients with Alzheimer’s Disease
【24h】

Seroprevalence of Toxoplasma gondii Infection in Patients with Alzheimer’s Disease

机译:阿尔茨海默氏病患者弓形虫感染的血清阳性率

获取原文
           

摘要

Background: Toxoplasmosis is one of the most important diseases in humans and animals. Almost one-third of the human population around the world is infected with toxoplasmosis. The agent of this parasitic disease is a protozoan called Toxoplasma gondii ( T. gondii ) that causes encephalitis in people with suppressed immune systems and abortion, mental retardation and chorioretinitis in the fetus. Alzheimer’s disease (AD) is the most important neurodegenerative disease. Objectives: Due to the high prevalence of toxoplasmosis in Iran and evidence on its impact on neurodegenerative diseases, this study was performed to evaluate the T. gondii infection in patients with AD. Patients and Methods: In this case-control study, after selection of alzheimer’s patients (APs) referred to Imam Reza psychiatric hospital of Khorramabad, west of Iran, and healthy controls (each group consisted of 87 individuals), using the convenience sampling method and under the supervision of a neurologist, blood samples were taken during July 2014 and January 2015. The collected samples were transferred to the research laboratory of parasitology under cold chain storage and then, the serum samples were separated by centrifugation and were frozen at -20°C until use. The T. gondii IgM and IgG specific antibodies were assessed in serum samples using commercial Enzyme Linked Immunosorbent Assay (ELISA) kits. Results: The overall prevalence of T. gondii infection in patients with AD and the control group, using ELISA assay, was obtained as 66.6% (58/87) and 56.32% (49/87), respectively (P = 0.99). In this study, there was no significant association between T. gondii infection and AD. On the other hand, no statistically significant difference was observed between the two groups in terms of infection with T. gondii (P = 0.99). Conclusions: Higher prevalence of T. gondii in patients with AD compared to controls showed the possible impact of this parasite in AD, which may exacerbate symptoms, and this requires special attention of specialists and patient families.
机译:背景:弓形虫病是人类和动物中最重要的疾病之一。全世界将近三分之一的人口感染了弓形虫病。这种寄生虫病的病原是一种称为弓形虫的原虫(弓形虫),可导致免疫系统受到抑制的人脑炎,并导致胎儿流产,智力低下和脉络膜视网膜炎。阿尔茨海默氏病(AD)是最重要的神经退行性疾病。目的:由于伊朗弓形虫病的高发病率及其对神经退行性疾病影响的证据,本研究旨在评估AD患者的弓形虫感染。患者和方法:在本病例对照研究中,选择了阿尔茨海默氏病患者(AP)后,采用便利抽样方法,将其转介至伊朗西部霍拉马巴德的伊玛目·雷扎精神病医院和健康对照者(每组包括87人)。在神经科医生的监督下,于2014年7月和2015年1月采集血液样本。收集的样本在冷链存储下转移至寄生虫学研究实验室,然后通过离心分离分离血清样本并在-20°C下冷冻C直到使用。使用商业酶联免疫吸附测定(ELISA)试剂盒评估血清样品中的弓形虫IgM和IgG特异性抗体。结果:采用ELISA测定,AD和对照组AD患者的弓形虫总感染率分别为66.6%(58/87)和56.32%(49/87)(P = 0.99)。在这项研究中,弓形虫感染与AD之间无显着关联。另一方面,就弓形虫的感染而言,两组之间均未观察到统计学上的显着差异(P = 0.99)。结论:与对照组相比,AD患者的弓形虫患病率更高,表明该寄生虫可能对AD产生影响,可能加剧症状,因此需要专业人员和患者家属特别注意。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号